🇺🇸 Tretinoin cream 0.05 in United States
50 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 50
Most-reported reactions
- Dry Skin — 10 reports (20%)
- Off Label Use — 8 reports (16%)
- Drug Ineffective — 7 reports (14%)
- Erythema — 6 reports (12%)
- Skin Exfoliation — 5 reports (10%)
- Skin Irritation — 4 reports (8%)
- Acne — 3 reports (6%)
- Application Site Pain — 3 reports (6%)
- Anxiety — 2 reports (4%)
- Application Site Erythema — 2 reports (4%)
Other Dermatology approved in United States
Frequently asked questions
Is Tretinoin cream 0.05 approved in United States?
Tretinoin cream 0.05 does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Tretinoin cream 0.05 in United States?
Massachusetts General Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.